KSU veterinary researchers, Anivive license FIP antiviral drugSeptember 20, 2018A collaboration at Kansas State University and Anivive Lifesciences is promoting the commercial development of GC376, an antiviral compound for feline infectious peritonitis (FIP), which previously has had no effective treatment or cure. Yunjeong Kim, DVM, PhD, ACVM, and Kyeong-Ok "KC" Chang, DVM, MS, PhD, virologists at KSU's College of Veterinary Medicine, and William Groutas, a medicinal chemist at Wichita State University, have been collaborating since 2006 to develop antiviral drugs …
SPONSORED CONTENTRevolutionize parvovirus care in your clinicPuppies treated with our Canine Parvovirus Monoclonal Antibody recovered faster: heading home from the clinic nearly two days earlier.1 Join 9 out of 10 satisfied veterinarians. + Read More